Genes and patent policy: rethinking intellectual property rights

被引：42

作者：

Andrews, LB ^{[1
]}

机构：

[1] Princeton Univ, Princeton, NJ 08544 USA

[2] Chicago Kent Coll Law, Chicago, IL 60661 USA

来源：

NATURE REVIEWS GENETICS | 2002年 / 3卷 / 10期

关键词：

D O I：

10.1038/nrg909

中图分类号：

Q3 [遗传学];

学科分类号：

071007 [遗传学]; 090102 [作物遗传育种];

摘要：

Concerns about human gene patents go beyond moral disquiet about creating a commodity from a part of the human body and also beyond legal questions about whether genes are unpatentable products of nature. New concerns are being raised about harm to public health and to research. In response to these concerns, various policy options, such as litigation, legislation, patent pools and compulsory licensing, are being explored to ensure that gene patents do not impede the practice of medicine and scientific progress.

引用

页码：803 / 808

页数：6

共 27 条

[1]

*AM COLL MED GEN, 1999, POS STAT GEN PAT ACC

[2]

ANAND G, 2001, WALL STREET J 0618, pB1

[3]

ANDREWS L, 2001, FUTURE PERFECT CONFR, P127

[4]

[Anonymous], 2001, WALL STR J

[5]

[Anonymous], AM U INT L REV

[6]

BENDER D, 2001, PATENTS CLAIMING COM

[7]

French challenge to BRCA1 patent underlies European discontent [J].

Benowitz, S .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (02) :80-81

[8]

BORGER J, 1999, GUARDIAN LOND 1215, P1

[9]

BORSELLINO M, 2000, MED POST, V36, P40

[10]

French researchers take a stand against cancer gene patent [J].

Butler, D ;

Goodman, S .

NATURE, 2001, 413 (6852) :95-96

← 1 2 3 →